好及施巴布剂治疗急性关节扭伤120例  被引量:1

Haojishi Babu Plaster in Treatment of Acute Joint Sprain in 120 Cases

在线阅读下载全文

作  者:邢立刚[1] 

机构地区:[1]四川省会理县人民医院,四川凉山615000

出  处:《中国药业》2015年第13期75-76,共2页China Pharmaceuticals

摘  要:目的探讨好及施巴布剂治疗急性关节扭伤的疗效。方法将120例患者随机分为对照组和观察组,各60例。对照组采用传统方案治疗,观察组采用好及施巴布剂治疗。结果观察组患者总有效率为73.33%,明显高于对照组的53.33%(P<0.05);两组患者治疗后疼痛视觉模拟评分(VAS)较治疗前均显著下降(P<0.05),但两组间未见明显差异(P>0.05);治疗后两组患者肿胀部位周长均较治疗前明显减少,且观察组减少程度更明显(P<0.05);观察组患者不良事件发生率较对照组明显降低(P<0.05)。结论好及施巴布剂能显著提高急性关节扭伤总体疗效,同时使用过程安全、不良反应少。Objective To investigate the effect of Haojishi Babu Plaster in treating acute joint sprain. Methods 120 cases of acute joint sprain were randomly divided into the control group and the observation group, 60 cases in each group. The control group adopted the conventional treatment scheme, while the observation group were treated by Haojishi Babu Plaster. Results The total effective rate in the observation group was significantly increased compared with the control group(73.33% vs. 53.33% ), the difference was statistically significant( P 〈 0. 05). The pain index after treatment in the two groups was significantly decreased compared with before treatment, the difference was statistically significant(P 〈 0. 05), but the difference in pain index between the two groups had no statistically sig- nificant difference( P 〉 0. 05). The injured joint swelling perimeter after treatment in the two groups was obvious reduced, the difference was statistically significant( P 〈 0. 05). The incidence rate of adverse reactions in the observation group was significantly lower than that in the control group(P 〈 0. 05). Conclusion Haojishi Babu Plaster can significantly improve the total curative effect in the patients with acute joint sprain, meanwhile which has safety during the use process and less adverse reactions.

关 键 词:好及施巴布剂 急性关节扭伤 临床疗效 安全性 

分 类 号:R969.4[医药卫生—药理学] R982[医药卫生—药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象